Keywords: CNI، مهار کننده کالسینورین; CsA, cyclosporine; CNI, calcineurin inhibitor; DAMP, damage-associated molecular pattern molecule; HMGB1, high-mobility group box1; IRI, ischemia-reperfusion injury; NF-κB, nuclear factor kappa B; PAMP, pathogen-associated molecule pattern molecule; RAGE,
مقالات ISI CNI، مهار کننده کالسینورین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CNI، مهار کننده کالسینورین; BMI, body mass index; BPAR, biopsy proved acute rejection; CNI, calcineurin inhibitor; DM, diabetes mellitus; ESLD, end stage liver disease; HCC, hepatocellular carcinoma; LT, liver transplantation; MELD, model of end stage liver disease; MMF, mycophenola
Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection
Keywords: CNI، مهار کننده کالسینورین; CNI, calcineurin inhibitor; CsA, cyclosporine A; hpf, high power field; IF/TA, interstitial fibrosis/tubular atrophy; KTx, kidney transplantation; MHC, major histocompatibility complex; MFI, mean fluorescence intensity; PBL, peripheral blood lymphocytes;
Effects of mTOR and calcineurin inhibitors combined therapy in Epstein–Barr virus positive and negative Burkitt lymphoma cells
Keywords: CNI، مهار کننده کالسینورین; BL, Burkitt lymphoma; BrdU, bromodeoxyuridine; CI, combination index; CNI, calcineurin inhibitor; CsA, cyclosporin A; EBV, Epstein–Barr virus; Eve, everolimus; LDH, lactate dehydrogenase; mTOR, mammalian target of rapamycin; mTORC1, mammalian target of ra
Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients
Keywords: CNI، مهار کننده کالسینورین; mTOR, mammalian target of rapamycin; MMF, mycophenolate mofetil; CNI, calcineurin inhibitor; SRL, sirolimus; TAC, tacrolimus; STAT, signal transducer and activator of transcription; mTORC1, mTOR complex 1; mTORC2, mTOR complex 2Calcineurin inhibitors; Reg
Lack of association between CD40 polymorphisms and acute rejection in German liver transplant recipients
Keywords: CNI، مهار کننده کالسینورین; AIH, autoimmune hepatitis; APCs, antigen presenting cells; AZA, azathioprine; bp, base pairs; BPAR, biopsy proven acute rejection; CD, cluster of differentiation; Cl, confidence interval; CNI, calcineurin inhibitor; f, female; HCV, hepatitis C virus; HBV,
Lack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients
Keywords: CNI، مهار کننده کالسینورین; AZA, azathioprine; bp, base pairs; CD, cluster of differentiation; Cl, confidence interval; CNI, calcineurin inhibitor; CTLA-4, cytotoxic T-lymphocyte-associated antigen 4; sCTLA-4, soluble cytotoxic T-lymphocyte-associated antigen 4; f, female; HCV, hepa
Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients
Keywords: CNI، مهار کننده کالسینورین; CYP450, cytochrome P450 enzymes; MDR, multidrug resistance; P-gp, P-glycoprotein; C/D ratio, tacrolimus concentration/dose ratio; ALT, alanine aminotransferase; ALP, alkaline phosphatase; CNI, calcineurin inhibitor; MA, microalbumin; IGU, urine immunoglob
Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach
Keywords: CNI، مهار کننده کالسینورین; AR, acute rejection; AUC, area under the plasma concentration vs. time curve; CC, concentration-controlled; CNI, calcineurin inhibitor; CSA, cyclosporine; FD, fixed-dose; HPLC, high-performance liquid chromatography; IMPDH II, inosine 5′ monophosphate deh
Current Status of Immunosuppression in Liver Transplantation
Keywords: CNI، مهار کننده کالسینورین; liver transplantation; immunosuppression; metabolic syndromeHLA, human leukocyte antigen; MAP, mitogen activated protein; NF-kB, nuclear factor kappa B; IL-2, interleukin-2; CNI, Calcineurin inhibitor; NFAT, nuclear factor of activated T cells; FKBP12, FK
The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors
Keywords: CNI، مهار کننده کالسینورین; CSA, cyclosporin A; CNI, calcineurin inhibitor; AZA, azathioprine; MMF, mycophenolate mofetil; CKD, chronic kidney disease; AR, acute rejectionGraft loss; Calcineurin inhibitors; Chronic nephrotoxicity; Chronic kidney disease; Kidney transplantation
Heart Transplantation Research in the Next Decade—A Goal to Achieving Evidence-Based Outcomes : National Heart, Lung, and Blood Institute Working Group
Keywords: CNI، مهار کننده کالسینورین; heart transplantation; NHLBI; research; working groupAMR, antibody mediated rejection; CAV, cardiac allograft vasculopathy; CNI, calcineurin inhibitor; HF, heart failure; HT, heart transplantation; LVAD, left ventricular assist device; NHLBI, National Hea
NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats
Keywords: CNI، مهار کننده کالسینورین; AP-1, activator protein-1; CNI, calcineurin inhibitor; DC, dendritic cell; ERK, extracellular signal-regulated kinase; JNK, c-Jun NH2-terminal kinase; MAPK, mitogen-activated protein kinase; MLR, mixed lymphocyte reaction; MST, median survival time; NF-κB
Phosphospecific flow cytometry for pharmacodynamic drug monitoring: Analysis of the JAK-STAT signaling pathway
Keywords: CNI، مهار کننده کالسینورین; CNI, Calcineurin inhibitor; IFN-γ, Interferon-γ; IL-2R, Interleukin-2 receptor; JAK, Janus tyrosine kinase; mAb, Monoclonal antibody; MFI, Median fluorescence intensity; MMF, Mycophenolate mofetil; NK cell, Natural killer cell; PBMC, Peripheral blood mono
Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing
Keywords: CNI، مهار کننده کالسینورین; AUC, area under the curve; BPAR, biopsy-proven acute rejection; CNI, calcineurin inhibitor; EC-MPS, enteric-coated mycophenolate sodium; ED, expert driven; GI, gastrointestinal; GSRS, Gastrointestinal Symptom Rating Scale; IMPDH, inosine monophosphate deh
Surface markers of lymphocyte activation and markers of cell proliferation
Keywords: CNI، مهار کننده کالسینورین; APC, Antigen Presenting Cell; BrdU, Bromodeoxyuridine; CD, Cluster of Differentiation; CNI, Calcineurin Inhibitor; CON, Concanvalin A; CFSE, Carboxyfluorescein Succinimidyl Ester; CTLA, Cytotoxic T Lymphocyte Antigen; CYA, Cyclopsorine A; EVER, Everolimus
ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantation
Keywords: CNI، مهار کننده کالسینورین; ABC, ATP-binding cassette; AUC, Area-under the concentration versus time-curve; BPAR, Biopsy-proven acute rejection; cMOAT, Canalicular multispecific organic anion transporter; CNI, Calcineurin inhibitor; CsA, Cyclosporine A; FDCC, Fixed-dose versus Conce
The role of B cells in solid organ transplantation
Keywords: CNI، مهار کننده کالسینورین; B cell; Antibody-mediated rejection; Chronic rejectionAMR, alloantibody-mediated rejection; MHC, major histocompatibility complex; BAFF, B-cell activating factor; APRIL, a proliferation-inducing ligand; CNI, calcineurin inhibitor; HLA, human leukocyte ant
Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation
Keywords: CNI، مهار کننده کالسینورین; C1H, alemtuzumab (Campath-1H); rATG, antithymocyte globulin (Thymoglobulin); Dac, daclizumab; Ritux, rituximab; CNI, calcineurin inhibitor; mTOR, mammalian target of rapamycin; MMF, mycophenolate mofetil; EC-MPS, enteric coated mycophenolate sodium; AR, a
Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine
Keywords: CNI، مهار کننده کالسینورین; CMV, cytomegalovirus; CNI, calcineurin inhibitor; CsA, cyclosporine; GFR, glomerular filtration rate; ITT, intent-to-treat; MMF, mycophenolate mofetil; NK, natural killer; NKT, natural killer T-lymphocyte; PRA, panel reactive antibodiesThymoglobulin; Siro
Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy
Keywords: CNI، مهار کننده کالسینورین; AST, aspartate transaminase; ALT, alanine transaminase; ALP, alkaline phosphatase; GGT, gamma glutamyl transpeptidase; ISPT, immunosuppressive treatment; CNi, calcineurin inhibitor; HCV, hepatitis C virus; PBS, phosphate buffered saline; FCS, fetal calf s
Transplant Coronary Artery Disease
Keywords: CNI، مهار کننده کالسینورین; drug-eluting stent; heart transplantationCMV, cytomegalovirus; CNI, calcineurin inhibitor; CT, computed tomography; HLA, human leukocyte antigen; IVUS, intravascular ultrasound; OHT, orthotopic heart transplantation; PCI, percutaneous coronary interventio
Pancreas Allotransplants in Patients with a Previous Total Pancreatectomy for Chronic Pancreatitis
Keywords: CNI، مهار کننده کالسینورین; CNI, calcineurin inhibitor; CSA, cyclosporine; IEQ, islet equivalents; IPTR, International Pancreas Transplant Registry; MMF, mycophenolate mofetil; PAK, pancreas after kidney transplant; PTA, pancreas transplant alone; SPK, simultaneous pancreas-kidney t
Costimulation blockade in autoimmunity and transplantation
Keywords: CNI، مهار کننده کالسینورین; Costimulation; abatacept; belatacept; organ transplantation; autoimmune disease; rheumatoid arthritisAPC, Antigen-presenting cell; CNI, Calcineurin inhibitor; CTLA4, Cytotoxic T lymphocyte–associated antigen 4; DMARD, Disease-modifying anti-inflammatory d
The Changing Face of Heart Transplantation
Keywords: CNI، مهار کننده کالسینورین; heart transplantation; heart failure; immunology; cardiac surgery; coronary artery diseaseAMR, antibody-mediated rejection; CHD, congenital heart disease; CNI, calcineurin inhibitor; GEP, gene expression profiling; HLA, human leukocyte antigen; ISHLT, Int
Transplantation Immunology: What the Clinician Needs to Know for Immunotherapy
Keywords: CNI، مهار کننده کالسینورین; APC, antigen-presenting cell; CNI, calcineurin inhibitor; CTLA-4, cytotoxic T lymphocyte–associated antigen 4; DC, dendritic cell; IL, interleukin; MHC, major histocompatibility complex; NK, natural killer; PD-1, programmed death-1; TCR, T-cell receptor;
Sirolimus-Induced Pulmonary Hypersensitivity Associated With a CD4 T-Cell Infiltrate
Keywords: CNI، مهار کننده کالسینورین; hypersensitivity; liver; rapamycin; sirolimus; transplantationBOOP, bronchiolitis obliterans organizing pneumonia; CNI, calcineurin inhibitor; HCV, hepatitis C virus; GIP, granulomatous interstitial pneumonitis; OP, organizing pneumonia; SRL-IPH, sirolimu
A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis
Keywords: CNI، مهار کننده کالسینورین; ACE, angiotensin-converting enzyme; BSA, body surface area; CNi, calcineurin inhibitor; ITT, intention-to-treat; PASI, Psoriasis Area and Severity Index; SGA, Static Global Assessment